Correction of Intensity of Bone Involvement (IBI) Index by Lean Body Mass and Body Surface Area




18F-FDG/PET-CT, Mieloma Múltiplo, Massa Corporal Magra, Área de Superfície Corporal, IBI


The Intensity of Bone Involvement (IBI) parameter is utilized to quantitatively assess bone involvement in PET/CT images of multiple myeloma (MM) patients, providing an objective and reproducible analytical approach. This study proposes the mathematical correction of IBI for lean body mass (LBM) and body surface area (BSA) in 18F-FDG PET/CT images of MM patients. Beyond the corrections, our aim is to evaluate the correlation of corrected IBIs and visual image analysis, along with their relationship with overall patient survival. Methods: This retrospective study analyzed 18F-FDG PET/CT images and clinical data from 73 MM patients. LBM was calculated using the James and Janma models, while BSA was calculated using the DuBois model. The conventionally calculated IBI parameter was then corrected for LBM and BSA. Three experienced nuclear medicine physicians visually classified the intensity of bone involvement as: negative, mild, moderate, marked, and very marked. We compared standard IBI and corrected indices with visual classification using Kruskal-Wallis test and Dunn's post-hoc test. Cox proportional hazards regression analysis was employed to test the association with overall patient survival. Statistical significance was established for p-values <0.05. Results: A positive relationship was observed between both standard IBI and its corrected values with visual image classification. No statistically significant association was found between IBI values and overall patient survival. Conclusions: IBI corrected for both LBM or BSA exhibited similar performance to standard IBI compared to visual image classification. However, IBI values (both standard and its corrections) were not associated with overall survival (OS) in our study.


Não há dados estatísticos.


Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046-60.

Jamet B, Bailly C, Carlier T, Touzeau C, Nanni C, Zamagni E, et al. Interest of Pet Imaging in Multiple Myeloma. Front Med (Lausanne). 2019; 6:69.

Panaroni C, Yee AJ, Raje NS. Myeloma and Bone Disease. Curr Osteoporos Rep. 2017; 15(5):483-98.

Zamagni E, Cavo M, Fakhri B, Vij R, Roodman D. Bones in Multiple Myeloma: Imaging and Therapy. Am Soc Clin Oncol Educ Book. 2018;38:638-46.

Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18(4):e206-e17.

Takahashi MES, Mosci C, Souza EM, Brunetto SQ, Etchebehere E, Santos AO, et al. Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma. Sci Rep. 2019;9(1):16429.

Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195(2):310-20.

Zhao J, Xue Q, Chen X, You Z, Wang Z, Yuan J, et al. Evaluation of SUVlean consistency in FDG and PSMA PET/MR with Dixon-, James-, and Janma-based lean body mass correction. EJNMMI Phys. 2021;8(1):17.

Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology. 1999;213(2):521-5.

Takahashi ME, Mosci C, Souza EM, Brunetto SQ, de Souza C, Pericole FV, Ramos CD. Computed tomography–based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma. Nuclear medicine communications. 2020;41(4):377.

da Cunha Júnior AD, Silveira MN, Takahashi MES, de Souza EM, Mosci C, Ramos CD, Carvalheira JBC, et al. Visceral adipose tissue glucose uptake is linked to prognosis in multiple

myeloma patients: An exploratory study. Clinical Nutrition. 2021; 40(6):4075-84.

Takahashi MES, Mosci C, Duarte GO, Pericole FV, Metze K, Lorand-Metze IG, Ramos CD. Intensity of bone involvement: A quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma. Nuclear medicine communications. 2021; 42(12):1375-81.

James, William Philip Trehearne, and J. C. Waterlow. Research on obesity: a report of the DHSS/MRC group. HM Stationery Office, 1976.

Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44(10):1051-65.

Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med. 1994;35(1):164-7.




Como Citar

Monteiro Bianchi J. Santos, G., Seren Takahashi, M. E., Mosci, C., P. M. Souza, S., de Souza , C. A., G. H. Lorand-Metze, I., Barreto Campello Carvalheira, J., & Ramos , C. D. (2024). Correction of Intensity of Bone Involvement (IBI) Index by Lean Body Mass and Body Surface Area. Revista Brasileira De Física Médica, 18, 754.



Artigo Original

Artigos mais lidos pelo mesmo(s) autor(es)